Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 29 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
281 22.3 months Hepatocellular carcinoma 4 Chemotherapy
National Cancer Center Hospital Japan 10/2009
Treatment Details: Patients: This phase III study involved 82 hepatocellular carcinoma patients with a median age of 67 years; 85.4% were male. Treatment: Patients were treated with the chemotherapy agent
 
282 22.3 months Adenocarcinoma of the lung 5 Biologic therapy
National Cancer Center Korea 2/2012
Treatment Details: Patients: This phase III study involved never-smokers with adenocarcinoma of the lung who had not received previous chemotherapy. Patients were separated into 2 treatment groups. Group A
 
283 22.3 months Hormone-refractory prostate cancer 4 Biologic therapy
Chemotherapy
University of Verona Italy 11/2008
Treatment Details: Patients: This phase 2 study involved 95 patients with hormone-refractory prostate cancer. They ranged in age from 48 to 86 years of age. Less than 20% had previously been treated with su
 
284 22.3 months Metastatic breast cancer 3 Biologic therapy
Chemotherapy
Tohoku University School of Medicine Japan 7/2009
Treatment Details: Patients: This phase 2 study involved 38 women with metastatic breast cancer. The median age was 53, ranging from 30 to 69 years. Most of them (68.4%) were post-menopausal. Treatment:
 
285 22.2 months Metastatic Colorectal Cancer 5 Biologic therapy
Chemotherapy
Cliniche Universitarie Convenzionate Italy 7/2009
Treatment Details: Patients: This study involved 209 patients with metastatic colorectal cancer, who had not received prior treatment. Of these, 60% were male. The median age was 62 years (range 31-82).
 
286 22.2 months Metastatic urothelial cancer 4 Biologic therapy
Chemotherapy
Massachusetts General Hospital Cancer Center United States 3/2012
Treatment Details: Patients: This study involved women with HER2-negative locally advanced or metastatic breast cancer who were divided into two separate treatment groups. Group A had 115 patients with an av
 
287 22.1 months Metastatic, castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Hormone
Princess Margaret Cancer Center Canada 7/2013
Treatment Details: Patients: This phase 3 study involved metastatic castration-resistant prostate cancer patients who had not received prior chemotherapy and who were divided into two separate treatment group
 
288 22.0 months Malignant pleural mesothelioma 5 Surgery
University Medical Center Freiburg Germany 2/2013
Treatment Details: Patients: This study involved 25 malignant pleural mesothelioma patients. The median patient age was 59 years and 20 were male. Treatment: Patients were treated with extrapleural pleur
 
289 22.0 months Metastatic colorecal cancer 4 Biologic therapy
Chemotherapy
Nihon University School of Medicine Japan 9/2013
Treatment Details: Patients: This phase 2 study involved 39 metastatic colorectal cancer patients. The median patient age was 65 years and 61.5% were male. Treatment: Patients were treated with the chemo
 
290 22.0 months Peripheral T-cell lymphoma 5 Biologic therapy
Chemotherapy
Hormone
Stanford University United States 7/2013
Treatment Details: Patients: This study involved 39 peripheral T-cell lymphoma (PTCL) and natural killer (NK) cell lymphoma patients with a median age of 60 years; 72% were male. Treatment: Patients were
 
Page 29 of 187  | Previous Page  | Next Page